Immunovant, Inc.

Immunovant, Inc. is a biopharmaceutical company based in the United States. The company is focused on developing treatments for autoimmune diseases, with a patient-centered approach to address the complex and variable needs of individuals affected by these conditions. Immunovant's pipeline includes ongoing clinical trials, and the company is committed to advancing new therapies to improve the lives of people with autoimmune diseases.